S. Ricci, M. Celani, T. Cantisani
Aug 1, 2006
Citations
0
Influential Citations
8
Citations
Quality indicators
Journal
Stroke
Abstract
Piracetam is a drug which has been marketed in several countries for many years as a “nootropic” agent (that is, a drug which has metabolic activity on human brain), and for the treatment of myoclonus. Recently, a Cochrane review has been published on efficacy of piracetam on ameliorating language in aphasic stroke patients; the drug has been reconsidered for acute stroke treatment as well. The objective of this review was to assess the effects of piracetam in acute presumed ischemic stroke. Randomized trials comparing piracetam with control, with at least mortality reported and entry to the trial within ≈48 hours of stroke onset. Two reviewers (S.R., M.G.C.) extracted data and assessed trial quality, and this was checked by the other 2 …